These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 1560199

  • 1. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia.
    Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA.
    J Immunol; 1992 Apr 15; 148(8):2390-4. PubMed ID: 1560199
    [Abstract] [Full Text] [Related]

  • 2. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K, Jacobson MR, Rak S, Meng Q, Sudderick RM, Kay AB, Lowhagen O, Hamid Q, Durham SR.
    Immunology; 1994 Jun 15; 82(2):192-9. PubMed ID: 7927488
    [Abstract] [Full Text] [Related]

  • 3. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics.
    Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR.
    Am J Respir Cell Mol Biol; 1993 Jan 15; 8(1):35-42. PubMed ID: 8417755
    [Abstract] [Full Text] [Related]

  • 4. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR, Nouri-Aria KT, Walker SM, Pajno GB, O'Brien F, Jacobson MR, Mackay IS, Durham SR.
    J Allergy Clin Immunol; 2001 Jun 15; 107(6):971-6. PubMed ID: 11398073
    [Abstract] [Full Text] [Related]

  • 5. Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin.
    Tsicopoulos A, Hamid Q, Varney V, Ying S, Moqbel R, Durham SR, Kay AB.
    J Immunol; 1992 Apr 01; 148(7):2058-61. PubMed ID: 1531996
    [Abstract] [Full Text] [Related]

  • 6. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.
    Varney VA, Hamid QA, Gaga M, Ying S, Jacobson M, Frew AJ, Kay AB, Durham SR.
    J Clin Invest; 1993 Aug 01; 92(2):644-51. PubMed ID: 8349803
    [Abstract] [Full Text] [Related]

  • 7. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Ying S, Durham SR, Jacobson MR, Rak S, Masuyama K, Lowhagen O, Kay AB, Hamid QA.
    Immunology; 1994 Jun 01; 82(2):200-6. PubMed ID: 7927489
    [Abstract] [Full Text] [Related]

  • 8. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.
    Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB.
    N Engl J Med; 1992 Jan 30; 326(5):298-304. PubMed ID: 1530827
    [Abstract] [Full Text] [Related]

  • 9. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
    Masuyama K, Till SJ, Jacobson MR, Kamil A, Cameron L, Juliusson S, Lowhagen O, Kay AB, Hamid QA, Durham SR.
    J Allergy Clin Immunol; 1998 Oct 30; 102(4 Pt 1):610-7. PubMed ID: 9802369
    [Abstract] [Full Text] [Related]

  • 10. Cytokine expression during allergen-induced late nasal responses: IL-4 and IL-5 mRNA is expressed early (at 6 h) predominantly by eosinophils.
    Nouri-Aria KT, O'Brien F, Noble W, Jabcobson MR, Rajakulasingam K, Durham SR.
    Clin Exp Allergy; 2000 Dec 30; 30(12):1709-16. PubMed ID: 11122208
    [Abstract] [Full Text] [Related]

  • 11. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3.
    Humbert M, Ying S, Corrigan C, Menz G, Barkans J, Pfister R, Meng Q, Van Damme J, Opdenakker G, Durham SR, Kay AB.
    Am J Respir Cell Mol Biol; 1997 Jan 30; 16(1):1-8. PubMed ID: 8998072
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.
    Schrezenmeier H, Thomé SD, Tewald F, Fleischer B, Raghavachar A.
    Exp Hematol; 1993 Feb 30; 21(2):358-65. PubMed ID: 8425573
    [Abstract] [Full Text] [Related]

  • 13. Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid.
    Nouri-Aria KT, Masuyama K, Jacobson MR, Rak S, Lowhagen O, Schotman E, Hamid Q, Durham S.
    Int Arch Allergy Immunol; 1998 Dec 30; 117(4):248-54. PubMed ID: 9876226
    [Abstract] [Full Text] [Related]

  • 14. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
    Savolainen J, Jacobsen L, Valovirta E.
    Allergy; 2006 Oct 30; 61(10):1184-90. PubMed ID: 16942566
    [Abstract] [Full Text] [Related]

  • 15. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.
    Broide DH, Paine MM, Firestein GS.
    J Clin Invest; 1992 Oct 30; 90(4):1414-24. PubMed ID: 1401075
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P, Tillie-Leblond I, Malaquin F, Durieu J, Wallaert B, Tonnel AB.
    Clin Exp Allergy; 1997 Apr 30; 27(4):379-88. PubMed ID: 9146930
    [Abstract] [Full Text] [Related]

  • 17. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T, Kimura H, Kurabayashi M, Kozawa K, Kato M.
    Immunol Lett; 2008 Jun 15; 118(1):88-95. PubMed ID: 18440651
    [Abstract] [Full Text] [Related]

  • 18. Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation.
    KleinJan A, Dijkstra MD, Boks SS, Severijnen LA, Mulder PG, Fokkens WJ.
    J Allergy Clin Immunol; 1999 Mar 15; 103(3 Pt 1):441-50. PubMed ID: 10069878
    [Abstract] [Full Text] [Related]

  • 19. Appearance of granulocyte-macrophage colony-stimulating factor activity at allergen-challenged cutaneous late-phase reaction sites.
    Massey W, Friedman B, Kato M, Cooper P, Kagey-Sobotka A, Lichtenstein LM, Schleimer RP.
    J Immunol; 1993 Feb 01; 150(3):1084-92. PubMed ID: 8423333
    [Abstract] [Full Text] [Related]

  • 20. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
    Nouri-Aria KT, Pilette C, Jacobson MR, Watanabe H, Durham SR.
    J Allergy Clin Immunol; 2005 Jul 01; 116(1):73-9. PubMed ID: 15990777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.